BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tomás TC, Eiriz I, Vitorino M, Vicente R, Gramaça J, Oliveira AG, Luz P, Baleiras M, Spencer AS, Costa LL, Liu P, Mendonça J, Dinis M, Padrão T, Correia M, Atalaia G, Silva M, Fiúza T. Neutrophile-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios as prognostic and response biomarkers for resectable locally advanced gastric cancer. World J Gastrointest Oncol 2022; 14(7): 1307-1323 [PMID: 36051098 DOI: 10.4251/wjgo.v14.i7.1307]
URL: https://www.wjgnet.com/1948-5204/full/v14/i7/1307.htm
Number Citing Articles
1
Shufu Hou, Dandan Song, Yelei Zang, Ruiqi Hao, Linchuan Li, Jiankang Zhu. Prognostic relevance of platelet lymphocyte ratio (PLR) in gastric cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysisFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1367990
2
Jin-On Jung, Juan I. Pisula, Xenia Beyerlein, Leandra Lukomski, Karl Knipper, Aram P. Abu Hejleh, Hans F. Fuchs, Yuri Tolkach, Seung-Hun Chon, Henrik Nienhüser, Markus W. Büchler, Christiane J. Bruns, Alexander Quaas, Katarzyna Bozek, Felix Popp, Thomas Schmidt. Deep Learning Histology for Prediction of Lymph Node Metastases and Tumor Regression after Neoadjuvant FLOT Therapy of Gastroesophageal AdenocarcinomaCancers 2024; 16(13): 2445 doi: 10.3390/cancers16132445
3
Jianguo Yang, Juncai Li, Qican Deng, Zhenzhou Chen, Kuan He, Yajun Chen, Zhongxue Fu. Effect of neoadjuvant chemotherapy combined with arterial chemoembolization on short-term clinical outcome of locally advanced gastric cancerBMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10712-w
4
Yoshinaga Okugawa, Masaki Ohi, Takahito Kitajima, Koki Higashi, Yuhki Sato, Shinji Yamashita, Ryo Uratani, Tadanobu Shimura, Hiroki Imaoka, Mikio Kawamura, Yuki Koike, Hiromi Yasuda, Shigeyuki Yoshiyama, Yoshiki Okita, Yuji Toiyama. Clinical feasibility of the preoperative C-reactive protein–albumin–lymphocyte index to predict short- and long-term outcomes of patients with gastric cancerJournal of Gastrointestinal Surgery 2024; 28(7): 1045 doi: 10.1016/j.gassur.2024.04.016
5
Xiao-Dong Zhu, Li-Xiang Zhang, Pan-Quan Luo, Hai Zhu, Zhi-Jian Wei, A-Man Xu. Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancerJournal of Cancer Research and Clinical Oncology 2023; 149(13): 12191 doi: 10.1007/s00432-023-05131-0
6
Pawel Jarmuzek, Klaudia Kozlowska, Piotr Defort, Marcin Kot, Agnieszka Zembron-Lacny. Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-AnalysisCancers 2023; 15(13): 3339 doi: 10.3390/cancers15133339
7
Ping’an Ding, Pengpeng Liu, Lingjiao Meng, Qun Zhao. Mechanisms and biomarkers of immune-related adverse events in gastric cancerEuropean Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01365-3
8
Magdalena Skórzewska, Agnieszka Pikuła, Katarzyna Gęca, Radosław Mlak, Karol Rawicz-Pruszyński, Katarzyna Sędłak, Iwona Paśnik, Wojciech P. Polkowski. Systemic inflammatory response markers for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancerCytokine 2023; 172: 156389 doi: 10.1016/j.cyto.2023.156389